Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

Mild Cognitive Impairment

Interventions

DRUG

Atorvastatin Oral Tablet

Atorvastatin pill 40 mg to be taken every night

Trial Locations (1)

RECRUITING

Johns Hopkins University, Bayview Medical Center, Baltimore

All Listed Sponsors

collaborator

The Richman Family Precision Medicine Center of Excellence in Alzheimer Disease

UNKNOWN

lead

Johns Hopkins University

OTHER